Product information
From Health Canada
Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.
Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.
Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.
- Natural Product Number (NPN):
- 80113434
- Market status:
- Not Marketed
- Licence Status:
- Active
- Brand name(s):
-
ProBio Supreme
;
Health First ProBio Supreme - Licence holder:
- Health First Network
- Dosage Form:
- Capsule, delayed release
- Recommended route of administration:
-
Oral
Sub population (Sub Pop.) | Quantity (Qty) | Frequency (Freq.) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sub Pop. | Age | Min. | Max. | UoM Footnote1 Age | Qty | Min. | Max. | UoM Qty | Freq. | Min. | Max. | UoM Freq. |
Children, adolescents and adults | 6 | year(s) | 1.0 | capsule | 1 | daily | ||||||
- Recommended use or purpose:
- Source of probiotics. Helps support intestinal/ gastrointestinal health. Could promote a favorable gut flora. Helps to manage acute infectious diarrhoea. Helps to manage and/ or reduce the risk of antibiotic-associated diarrhoea.
- Risk Information:
- Cautions and Warnings
- Consult a health care practitioner prior to use if you have fever, vomiting, bloody diarrhoea or severe abdominal pain. Stop use and consult a health care practitioner if symptoms of digestive upset occur, worsen and/ or persists beyond 3 days.
- Contra-Indications
- Do not use this product if you have an immune-compromised condition.
Medicinal ingredients | Quantity (Qty) | Extract | Potency |
---|---|---|---|
Bifidobacterium animalis subsp. lactis |
0.55 billion cfu
|
||
Bifidobacterium bifidum |
1.375 billion cfu
|
||
Bifidobacterium breve |
1.1 billion cfu
|
||
Bifidobacterium longum subsp. infantis |
0.55 billion cfu
|
||
Bifidobacterium longum subsp. longum |
7.425 billion cfu
|
||
Lacticaseibacillus paracasei |
2.888 billion cfu
|
||
Lactiplantibacillus plantarum |
17.6 billion cfu
|
||
Lactobacillus acidophilus |
2.2 billion cfu
|
||
Lactobacillus casei |
6.325 billion cfu
|
||
Lactobacillus fermentum |
0.275 billion cfu
|
||
Lactobacillus reuteri |
0.138 billion cfu
|
||
Lactobacillus rhamnosus |
10.45 billion cfu
|
||
Lactobacillus rhamnosus |
3.85 billion cfu
|
||
Ligilactobacillus salivarius |
0.275 billion cfu
|
- List of non-medicinal ingredients:
-
- Fructooligosaccharides
- Gellan gum
- Hypromellose
- L-Leucine
- Oryza sativa (Rice) hull powder
- Potato Starch
- Date of licensing:
- 2021-10-13
- Revised date of licence:
Application information
Related information
Contact us
For technical support or if you have general questions concerning the content of this database, please contact the Natural Health Products Directorate (NHPD).